Germany’s Dr. Wolff is popping to Brazil as a strategic driver of development

The German, family-owned Dr. Wolff Group, a specialist in hygiene, skincare, hair care, and oral care, has now entered the Brazilian market. Backed by 120 years of historical past and operations in roughly 70 international locations, the corporate has excessive expectations for its enlargement there.

“Though we’re over a century previous, we solely started our worldwide enlargement about 25 years in the past. As a German firm, our strategic precedence was to consolidate our presence in Europe after which broaden into the Far East,” explains Tomas Schulz, Vice President of Gross sales for South America.

Nonetheless, Brazil had been on the group’s radar for a while, however tax and regulatory hurdles delayed its entry into the nation. “Launching a product in Brazil entails a degree of complexity hardly ever seen in different markets. Now that we’re formally current, the time has come to broaden our footprint within the nation.”

First ever funding in Latin America

Brazil marks the group’s first totally owned subsidiary in Latin America. “It’s the area’s most compelling market and can act as a launchpad for our broader enlargement. Whereas we’re already current in some Latin American international locations, our operations there have to date been restricted to distributor partnerships,” the manager says.

For its debut within the Brazilian market, Dr. Wolff has chosen to prioritize two of its manufacturers: Alpecin, specializing in males’s hair care and hair loss options; and Bioniq, a model targeted on oral hygiene and identified for its merchandise containing 20% biomimetic hydroxyapatite (HAP), the mineral that makes up 97% of pure tooth enamel.

“Alpecin usually serves as our spearhead in new markets, led by its flagship caffeine-based shampoo, the primary of its type globally. In Brazil, the place oral hygiene is a precedence for shoppers, we additionally determined to launch Bioniq, a model we imagine has vital potential. Our objective is to leverage the scale of this section with a particular different to present choices,” provides Tomas Schulz.

The group’s portfolio consists of seven proprietary manufacturers, amongst them Plantur 39, which affords hair care merchandise tailor-made to ladies over 40; Alcina, spanning skincare, hair care, and make-up; and Vagisan, targeted on female well being. “Our objective is to introduce all of those manufacturers to the Brazilian market,” says Harumi Iamamoto, Nation Supervisor of Dr. Wolff in Brazil.

A complete three-year launch plan

“New merchandise will likely be launched earlier than the top of 2026. The subsequent model to reach on the Brazilian market will seemingly be Plantur, a female model of Alpecin, which has sturdy potential. Our objective is to roll out our whole product portfolio in Brazil inside roughly three years,” reveals Ms. Iamamoto.

For its enlargement into Brazil, the German group has signed an unique settlement with the Raia and Drogasil pharmacy chains, subsidiaries of RD Saúde, the nation’s main pharmaceutical distribution group, which boasts over 3,400 bodily factors of sale and can be a significant on-line retailer. “It is a enterprise mannequin we’ve already carried out in different international locations. We selected the market chief to profit from nationwide distribution and acquire client belief. RD Saúde is an ideal match for our manufacturers, and this partnership may very well be long-term,” emphasizes Tomas Schulz.

In accordance with him, Dr. Wolff has very excessive ambitions for its new enterprise in Brazil. “Whereas Germany will stay our major market, Brazil ought to sooner or later change into our second largest on the earth. I’m satisfied we now have the potential.“